| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.029 | 0.6 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.072 | 0.6 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |